Cargando…
Intestinal Microbiota‐Generated Metabolite Trimethylamine‐N‐Oxide and 5‐Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE‐Like Patient Cohort
BACKGROUND: Trimethylamine‐N‐oxide (TMAO), a metabolite derived from gut microbes and dietary phosphatidylcholine, is linked to both coronary artery disease pathogenesis and increased cardiovascular risks. The ability of plasma TMAO to predict 5‐year mortality risk in patients with stable coronary a...
Autores principales: | Senthong, Vichai, Wang, Zeneng, Li, Xinmin S., Fan, Yiying, Wu, Yuping, Wilson Tang, W. H., Hazen, Stanley L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937244/ https://www.ncbi.nlm.nih.gov/pubmed/27287696 http://dx.doi.org/10.1161/JAHA.115.002816 |
Ejemplares similares
-
Trimethylamine N‐Oxide and Mortality Risk in Patients With Peripheral Artery Disease
por: Senthong, Vichai, et al.
Publicado: (2016) -
Gut microbiota-generated metabolite, trimethylamine-N-oxide, and subclinical myocardial damage: a multicenter study from Thailand
por: Senthong, Vichai, et al.
Publicado: (2021) -
Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD)
por: Amrein, Melissa, et al.
Publicado: (2022) -
Effects of Smoking and Smoking Cessation on the Intestinal Microbiota
por: Sublette, Marcus G., et al.
Publicado: (2020) -
Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine-N-Oxide
por: Romano, Kymberleigh A., et al.
Publicado: (2015)